| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |